Fig. 2From: Comparison of the regressive effects of aflibercept and brolucizumab on pigment epithelial detachmentMean changes from baseline in the maximum height (MH) of pigment epithelial detachment measured in the intravitreal aflibercept (IVA) and intravitreal brolucizumab (IVBr) groups before and at 1, 2, and 3 months after the first treatment. *: P < 0.05, ***: P < 0.001Back to article page